Biosurfit Company
Biosurfit develops breakthrough technologies that enable fast, precise and affordable blood analysis at the point of care.
Technology:
Genetic Test & Molecular Diagnostics
Industry:
Deep Diagnostics
Headquarters:
Lisbon, Lisboa, Portugal
Founded Date:
01.01.2006
Employees Number:
51-100
Funding Status:
Early Stage Venture
Investors Number:
4
Total Funding:
€10M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Series A
Register and Claim Ownership